Literature DB >> 24048740

The clathrin-dependent localization of dopamine transporter to surface membranes is affected by α-synuclein.

Haya Kisos1, Tziona Ben-Gedalya, Ronit Sharon.   

Abstract

Parkinson's disease (PD) is a progressive age-dependent neurodegenerative disorder, predominantly affecting the dopamine-producing neurons residing at the substantia nigra. Abnormalities in α-synuclein (α-Syn) and dopamine transporter (DAT) are implicated in the pathogenesis of PD. We tested the hypothesis that α-Syn regulates surface DAT localization and DAT activity, in cultured cells co-expressing α-Syn and DAT, and in brains of mice modeling PD, transgenic for the mutant A53T α-Syn form. The results indicate that α-Syn expression affects the partitioning of DAT between the cell surface and intracellular compartments, resulting in lower surface DAT levels. Accordingly, lower uptake of tritiated dopamine was measured in synaptosomes of A53T α-Syn transgenic mouse brains. Importantly, we show that the effect of α-Syn on surface DAT is mediated by clathrin. Downregulation of clathrin by specific siRNAs directed against its heavy chain abolished the effect of α-Syn on phorbol 12-myristate 13-acetate-induced DAT internalization. These results suggest that α-Syn plays a role in regulating dopamine homeostasis through its involvement in clathrin-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048740     DOI: 10.1007/s12031-013-0118-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  52 in total

1.  Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

Authors:  F J Lee; F Liu; Z B Pristupa; H B Niznik
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

Review 2.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors:  C Mehler-Wex; P Riederer; M Gerlach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

3.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

4.  Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.

Authors:  Xiangmin Peng; Xiangmin M Peng; Roya Tehranian; Paula Dietrich; Leonidas Stefanis; Ruth G Perez
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

Review 5.  Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

Authors:  Jacob Eriksen; Trine Nygaard Jørgensen; Ulrik Gether
Journal:  J Neurochem       Date:  2010-01-18       Impact factor: 5.372

6.  Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells.

Authors:  Christophe Wersinger; Melanie Banta; Anita Sidhu
Journal:  Neurosci Lett       Date:  2004-03-25       Impact factor: 3.046

7.  PI 3-kinase regulation of dopamine uptake.

Authors:  Lucia Carvelli; José A Morón; Kristopher M Kahlig; Jasmine V Ferrer; Namita Sen; James D Lechleiter; L M Fredrik Leeb-Lundberg; Gerald Merrill; Eileen M Lafer; Lisa M Ballou; Toni S Shippenberg; Jonathan A Javitch; Richard Z Lin; Aurelio Galli
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

Review 8.  Dopamine transporter mutant mice in experimental neuropharmacology.

Authors:  Raul R Gainetdinov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-05       Impact factor: 3.000

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

10.  Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.

Authors:  Abdelmojib Al-Wandi; Natalia Ninkina; Steven Millership; Sally J M Williamson; Paul A Jones; Vladimir L Buchman
Journal:  Neurobiol Aging       Date:  2008-12-20       Impact factor: 4.673

View more
  14 in total

1.  Journal of molecular neuroscience: impacting our brains.

Authors:  Illana Gozes
Journal:  J Mol Neurosci       Date:  2014-11       Impact factor: 3.444

Review 2.  Role of the endolysosomal system in Parkinson's disease.

Authors:  D J Vidyadhara; John E Lee; Sreeganga S Chandra
Journal:  J Neurochem       Date:  2019-07-31       Impact factor: 5.372

3.  Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.

Authors:  J L Barr; B A Rasmussen; C S Tallarida; J L Scholl; G L Forster; E M Unterwald; S M Rawls
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

4.  rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population.

Authors:  Cíntia Barros Santos-Rebouças; Andressa Pereira Gonçalves; Jussara Mendonça Dos Santos; Bianca Barbosa Abdala; Luciana Branco Motta; Jerson Laks; Margarete Borges de Borges; Ana Lúcia Zuma de Rosso; João Santos Pereira; Denise Hack Nicaretta; Márcia Mattos Gonçalves Pimentel
Journal:  Neuromolecular Med       Date:  2017-05-31       Impact factor: 3.843

Review 5.  Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges.

Authors:  Lauren R Kett; William T Dauer
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

6.  Synucleins regulate the kinetics of synaptic vesicle endocytosis.

Authors:  Karina J Vargas; Sachin Makani; Taylor Davis; Christopher H Westphal; Pablo E Castillo; Sreeganga S Chandra
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

7.  Loss of the transcription factor Meis1 prevents sympathetic neurons target-field innervation and increases susceptibility to sudden cardiac death.

Authors:  Fabrice Bouilloux; Jérôme Thireau; Stéphanie Ventéo; Charlotte Farah; Sarah Karam; Yves Dauvilliers; Jean Valmier; Neal G Copeland; Nancy A Jenkins; Sylvain Richard; Frédéric Marmigère
Journal:  Elife       Date:  2016-02-08       Impact factor: 8.140

Review 8.  Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

Authors:  Benjamin Ettle; Johannes C M Schlachetzki; Jürgen Winkler
Journal:  Mol Neurobiol       Date:  2015-05-13       Impact factor: 5.590

9.  Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson's Disease: An In Situ Proximity Ligation Assay Study.

Authors:  Francesca Longhena; Gaia Faustini; Cristina Missale; Marina Pizzi; Arianna Bellucci
Journal:  Int J Mol Sci       Date:  2018-05-30       Impact factor: 5.923

10.  Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour.

Authors:  Carlo Breda; Marie L Nugent; Jasper G Estranero; Charalambos P Kyriacou; Tiago F Outeiro; Joern R Steinert; Flaviano Giorgini
Journal:  Hum Mol Genet       Date:  2014-10-09       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.